{"id":7596,"date":"2022-11-22T13:00:22","date_gmt":"2022-11-22T10:00:22","guid":{"rendered":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/"},"modified":"2022-11-22T13:00:22","modified_gmt":"2022-11-22T10:00:22","slug":"tathmini-ya-kunusa-katika-wagonjwa-waliolazwa-hospitalini-na-waliojitenga-na-covid-19-katika-kituo-kimoja-katika-kesi-55","status":"publish","type":"post","link":"https:\/\/urbancare.clinic\/sw\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/","title":{"rendered":"Tathmini ya kunusa katika wagonjwa waliolazwa hospitalini na waliojitenga na COVID-19: uzoefu wa kituo kimoja kwenye kesi 55."},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/02\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg\" class=\"ff-og-image-inserted\" style=\"display:none\"><\/div>\n<p><span class=\"highwire-journal-article-marker-start\"><\/span><\/p>\n<div class=\"section intro\" id=\"sec-5\" readability=\"11.766990291262\">\n<h2 class>Utangulizi<\/h2>\n<p id=\"p-6\">Kupoteza harufu ni mojawapo ya dalili za kawaida katika maambukizi ya COVID-19.<a id=\"xref-ref-1-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-1\">1 2<\/a> Tafiti nyingi zilitathmini utendakazi wa kunusa unaoripotiwa kibinafsi, ilhali tafiti chache tu ndizo zilizotathmini wagonjwa kimakosa.<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-3\">3\u20137<\/a> Madhumuni ya utafiti wetu yalikuwa kutathmini uwezo wa kunusa katika wagonjwa waliolazwa hospitalini na waliojitenga nyumbani na wagonjwa wa COVID-19 na kulinganisha matokeo haya na utendaji wa kunusa unaojidhihirisha wenyewe.<\/p>\n<\/div>\n<div class=\"section methods\" id=\"sec-6\" readability=\"39.278936657339\">\n<h2 class>Mbinu<\/h2>\n<div id=\"sec-7\" class=\"subsection\" readability=\"18\">\n<h3>Washiriki wa masomo<\/h3>\n<p id=\"p-7\">Utafiti huo ulifanywa kwa wagonjwa 55 watu wazima walio na COVID-19 waliokuwa na swab\/aspirate chanya ya maambukizi ya SARS-CoV-2, ambao walitibiwa katika idara ya COVID-19 (Idara ya Magonjwa ya Kuambukiza, Kituo cha Matibabu cha Chuo Kikuu cha Ljubljana) au walipaswa kwa kozi kali ya ugonjwa, kujitenga nyumbani. Wagonjwa 24 walio na kozi kali ya COVID-19 walipimwa hospitalini kuelekea mwisho wa awamu ya papo hapo ya ugonjwa huo (wagonjwa waliolazwa hospitalini na COVID-19), wakati wagonjwa walikuwa thabiti, bila kuhitaji msaada wa kupumua au nyongeza ya oksijeni. Wagonjwa thelathini na moja walipimwa katika mpangilio wa wagonjwa wa nje baada ya mwisho wa kujitenga (wagonjwa waliojitenga nyumbani na COVID-19). Kikundi cha udhibiti kilikuwa na wagonjwa 44 waliofuatana ambao walitembelea kliniki ya jumla ya wagonjwa wa nje ya neva kwa sababu ya malalamiko kama vile kizunguzungu, kipandauso na ugonjwa wa neva wa entrapment, na ambao hawakuwa na shaka ya hali ya neurodegenerative au dalili za maambukizi ya kupumua katika miezi 2 iliyopita. Tathmini zilifanywa kati ya Machi na Mei 2020. Kwa maelezo zaidi kuhusu mbinu angalia faili ya 1 ya Nyongeza.<\/p>\n<\/div>\n<div id=\"sec-8\" class=\"subsection\" readability=\"42.358208955224\">\n<h3>Tathmini ya kunusa<\/h3>\n<p id=\"p-8\">Utendaji wa kunusa unaojiripoti ulitathminiwa kwa kuwauliza washiriki kukadiria utendaji wao wa kunusa unaotambulika kulingana na kipimo kutoka 1 hadi 10, ambapo 1 inamaanisha hakuna uwezo wa kunusa na 10 haiwakilishi matatizo yoyote. Pia walikadiria kizuizi cha pua kwenye mizani kutoka 1 hadi 10, ambapo 1 inamaanisha kizuizi kamili cha pua na 10 inawakilisha uwezo kamili wa pua. Kwa kuongezea, wagonjwa walio na COVID-19 waliulizwa juu ya uwepo wa parosmia kwa swali &#039;Tangu kuwa mgonjwa, ubora wa harufu yako ulibadilika, kwa mfano unaweza kunusa vitu ambavyo havipo&#039;.<\/p>\n<p id=\"p-9\">Madhumuni, harufu iliyoidhinishwa Vijiti vya Burghart Sniffin&#039; &#039;Screening 12 Test&#039; (Burghart Instruments, Wedel, Ujerumani) vilitumiwa wakati huo, vikiwa na manukato 12 ya kila siku (<a id=\"xref-table-wrap-1-1\" class=\"xref-table\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#T1\">meza 1<\/a>).<a id=\"xref-ref-8-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-8\">8 9<\/a> Kulingana na kanuni iliyothibitishwa ya Vijiti vya Burghart Sniffin&#039;, wagonjwa wa kawaida walihitaji 10, hyposmic 6-10 na wagonjwa wa ansomic 0-5 majibu sahihi. Kwa kuwa uwezo wa kunusa pia unategemea umri na jinsia, kila mshiriki alipewa kiwango cha asilimia (chini ya 10, 10-50, 50-90, zaidi ya 90) kulingana na chati zinazoandamana .<a id=\"xref-ref-9-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-9\">9<\/a>\n<\/p>\n<div id=\"T1\" class=\"table pos-float\" readability=\"5.2666666666667\">\n<div class=\"table-inline table-callout-links\">\n<div class=\"callout\"><span>Tazama jedwali hili:<\/span><\/div>\n<\/div>\n<div class=\"table-caption\" readability=\"7\"><span class=\"table-label\">Jedwali 1<\/span> <\/p>\n<p id=\"p-10\" class=\"first-child\">Tabia za washiriki na matokeo ya mtihani wa harufu<\/p>\n<\/div>\n<\/div>\n<p id=\"p-12\">Kwa kuongeza, washiriki walijaza dodoso la kumbukumbu za magonjwa, ikiwa ni pamoja na rhinosinusitis ya muda mrefu, ugonjwa wa mapafu na moyo, kisukari, shinikizo la damu, jeraha la kichwa, saratani, matibabu na chemotherapy au radiotherapy, pamoja na hali ya kuvuta sigara.<\/p>\n<\/div>\n<div id=\"sec-9\" class=\"subsection\" readability=\"21\">\n<h3>Uchambuzi wa takwimu<\/h3>\n<p id=\"p-13\">Kifurushi cha Takwimu cha IBM cha Sayansi ya Jamii kwa Windows, programu ya Sayansi V.23 (IBM Corporation, Armonk, New York, USA) ilitumika. Ili kutathmini tofauti kati ya wagonjwa waliolazwa hospitalini walio na COVID-19, wagonjwa waliojitenga nyumbani walio na COVID-19 na vidhibiti vya vibadilishio vya harufu (asilimia, na anuwai ya hali ya kawaida, hyposmia na anosmia) na magonjwa yanayoambatana, kipimo halisi cha Fisher kilitumiwa. Mtihani wa Kruskal-Wallis ulitumika kupima tofauti katika jumla ya alama (kama jumla ya majibu sahihi kwa harufu zote 12), na kwa kujitathmini kwa harufu na kuziba pua. Urejeshaji wa mstari ulitumiwa kutathmini uhusiano kati ya utendaji wa kunusa (jumla ya alama kwenye Jaribio la 12) na muda tangu kuambukizwa COVID-19 (idadi ya siku kutoka usufi chanya hadi kupima). Uchanganuzi wa uunganisho wa Spearman ulifanywa ili kuelezea uhusiano kati ya tathmini ya harufu ya kibinafsi na ya nusu-lengo, na pia kwa kulinganisha tathmini ya kibinafsi au alama ya jumla kwenye Uchunguzi wa 12 na kizuizi cha pua cha kujitathmini. Vigezo vya kitengo vinawasilishwa kama idadi ya matukio (asilimia), wastani unaoendelea (IQR\u2014IQR). Majaribio yote yalikuwa na mikia miwili na thamani ya p&lt;0.05 ikizingatiwa kuwa muhimu kitakwimu.<\/p>\n<\/div>\n<div id=\"sec-10\" class=\"subsection\" readability=\"7\">\n<h3>Uidhinishaji wa kawaida wa itifaki na ridhaa ya mgonjwa<\/h3>\n<p id=\"p-14\">Wagonjwa wote walitoa kibali cha habari kwa ajili ya kushiriki katika utafiti.<\/p>\n<\/div>\n<\/div>\n<div class=\"section results\" id=\"sec-11\" readability=\"48.460055096419\">\n<h2 class>Matokeo<\/h2>\n<p id=\"p-15\">Matokeo ya mtihani wa kunusa na mitazamo ya washiriki wanaohusika yanawasilishwa <a id=\"xref-table-wrap-1-2\" class=\"xref-table\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#T1\">meza 1<\/a>. Wagonjwa waliolazwa hospitalini walio na COVID-19 waliamua kwa usahihi 6.5 (IQR 5) ikilinganishwa na 10 (IQR 2) katika hali ya kujitenga na 11 (IQR 3) katika kikundi cha udhibiti (p&lt;0.001) (wamelazwa hospitalini dhidi ya kujitenga na kulazwa hospitalini dhidi ya udhibiti , p&lt;0.001, kujitenga dhidi ya vidhibiti, p=0.494). Kulikuwa na wagonjwa 66.7% waliolazwa hospitalini na wagonjwa wa COVID-19, 3.2% waliojitenga na vidhibiti vya COVID-19 na 15.9% ambao walipata chini ya asilimia 10 ya harufu ya jinsia na umri (p&lt;0.001) (walilazwa hospitalini dhidi ya kujitenga na kulazwa hospitalini dhidi ya vidhibiti, p&lt;0.001; kujitenga dhidi ya vidhibiti, p=0.130). Urejeshaji wa mstari ulionyesha uhusiano mkubwa kati ya uwezo wa kunusa na wakati uliopita kutoka kwa usufi chanya kwa maambukizi ya SARS-CoV-2 (F (1, 51)=14.949, p&lt;0.001, R<sup>2<\/sup>=0.222).<\/p>\n<p id=\"p-16\">Wagonjwa waliolazwa hospitalini walio na COVID-19 walikadiria uwezo wao wa kunusa kwa wastani 5 (IQR 7) ikilinganishwa na 8 (IQR 2) kwa wagonjwa waliojitenga na COVID-19 na 9 (IQR 3) katika kikundi cha kudhibiti (<a id=\"xref-table-wrap-1-3\" class=\"xref-table\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#T1\">meza 1<\/a>, p&lt;0.001). Uwiano kati ya tathmini ya kibinafsi na upimaji wa harufu ya nusu dhamira haukuwa muhimu katika hospitali (p=0.423, mgawo wa uwiano wa Spearman=0.176) na wagonjwa waliojitenga na COVID-19 (p=0.449, mgawo wa uunganisho wa Spearman=0.141), katika udhibiti wa afya, kulikuwa na uwiano mzuri wa wastani (p=0.001, mgawo wa uwiano wa Spearman=0.499). Hakukuwa na uhusiano kati ya uwezo wa kujitathmini wa kunusa na kizuizi cha pua cha kujitathmini katika vikundi vyote viwili vya COVID-19 (waliolazwa hospitalini COVID-19, p=0.945, mgawo wa uwiano wa Spearman=0.018, COVID-19 ya kujitenga, p=0.147, Spearman&#039;s mgawo wa uunganisho=0.267), hata hivyo waliunganishwa hafifu katika kikundi cha kudhibiti (p=0.022, mgawo wa uunganisho wa Spearman=0.343). Kwa kuongezea, hakukuwa na uhusiano wowote kati ya kujitathmini kibinafsi kwa kizuizi cha pua na matokeo ya &#039;Screening 12 Test&#039; (acute COVID-19 p=0.622, mgawo wa uwiano wa Spearman=0.129, COVID-19 p=0.502, uwiano wa Spearman mgawo = -0.125, kikundi cha udhibiti p=0.499, mgawo wa uwiano wa Spearman=0.105).<\/p>\n<p id=\"p-17\">61.8% tu ya wagonjwa walijibu swali juu ya mabadiliko ya ubora katika harufu. Parosmia ilikuwepo katika wagonjwa 4 (33.3%) waliolazwa hospitalini na wagonjwa 11 (50.0%) waliojitenga (p=0.350) waliokuwa na COVID-19. Vikundi hivi vitatu havikutofautiana katika magonjwa yanayofanana. (<a id=\"xref-table-wrap-2-1\" class=\"xref-table\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#T2\">meza 2<\/a>), isipokuwa kutoka kwa mzio na fetma. Washiriki kutoka kwa kikundi cha udhibiti walikuwa na mizio zaidi (11 (25.6%)) ikilinganishwa na wagonjwa waliojitenga na COVID-19 (3 (10.0%)) na wagonjwa waliolazwa hospitalini na COVID-19 (p=0.042). Wagonjwa waliolazwa hospitalini walio na COVID-19 walikuwa na uwezekano mkubwa wa kuwa wanene (4 (26.7%)) ikilinganishwa na wagonjwa waliojitenga na vidhibiti vya COVID-19 na (3 (7.0%)) (p=0.011).<\/p>\n<div id=\"T2\" class=\"table pos-float\" readability=\"5.2142857142857\">\n<div class=\"table-inline table-callout-links\">\n<div class=\"callout\"><span>Tazama jedwali hili:<\/span><\/div>\n<\/div>\n<div class=\"table-caption\" readability=\"7\"><span class=\"table-label\">Jedwali 2<\/span> <\/p>\n<p id=\"p-18\" class=\"first-child\">Magonjwa ya washiriki na hali ya kuvuta sigara<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"section discussion\" id=\"sec-12\" readability=\"61.326684397163\">\n<h2 class>Majadiliano<\/h2>\n<p id=\"p-21\">Matokeo makuu ya utafiti wetu ni: (1) Hyposmia au anosmia ilikuwepo katika idadi kubwa ya wagonjwa waliolazwa hospitalini (87.5%), na theluthi mbili ya wagonjwa waliolazwa hospitalini na COVID-19 wakiwa chini ya asilimia 10 kwa umri na jinsia zao, (2) Utendaji wa harufu uliharibika zaidi kwa wagonjwa waliolazwa hospitalini walio na COVID-19 ikilinganishwa na wagonjwa waliojitenga na COVID-19 nyumbani na washiriki wa kudhibiti, na (3) Uwiano kati ya ukadiriaji wa harufu na upimaji wa harufu usiotarajiwa haukutegemewa. kwa wagonjwa waliolazwa hospitalini na waliojitenga na COVID-19, lakini sio washiriki wa udhibiti.<\/p>\n<p id=\"p-22\">Ugunduzi wetu kwamba idadi kubwa ya wagonjwa waliolazwa hospitalini walikuwa na kiwango fulani cha upotezaji wa harufu ni muhimu. Masomo ya awali, ambayo yote yalitumia ripoti za wagonjwa, ziliripoti kuwa upotezaji wa harufu kwa wagonjwa walio na COVID-19 unaweza kuhusishwa na kozi dhaifu ya ugonjwa huo.<a id=\"xref-ref-10-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-10\">10\u201313<\/a> Hii ni tofauti kabisa na matokeo yetu, ambapo 87.5% ya wagonjwa waliolazwa hospitalini kutokana na kozi kali ya COVID-19 ilionyesha hyposmia au anosmia wakati wa kupima kunusa. Vile vile, Moein <em>na wengine<\/em> iligundua kuwa 96% ya wagonjwa waliolazwa hospitalini walionyesha kutokuwa na uwezo wa kupimika wa kunusa, huku 18% ikiwa ya kutojali. Sababu ya hitilafu inawezekana ni kutokana na ukweli kwamba tafiti zinazojiripoti huwa hazizingatii kuenea kwa upotevu wa kunusa kwa wagonjwa walio na COVID-19.<a id=\"xref-ref-3-2\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-3\">3 4 6 7 11 14\u201317<\/a> na hii inaweza kuwa dhahiri hasa kwa wagonjwa wenye ugonjwa mkali wa kupumua. Hakika, imependekezwa kuwa utendakazi wa kunusa unaweza kupuuzwa au kusahaulika katika hali ya ugonjwa mkali, usaidizi wa uingizaji hewa, na kupona kwa muda mrefu.<a id=\"xref-ref-4-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-4\">4<\/a>\n<\/p>\n<p id=\"p-23\">Utendaji wa harufu uliharibika zaidi katika hospitali ikilinganishwa na wagonjwa waliojitenga na COVID-19 na washiriki wa kudhibiti. Hii inaweza kuelezewa na wakati uliopita kutoka kwa kuambukizwa hadi upimaji wa kunusa, ambao ulikuwa mrefu katika kikundi kilichojitenga. Hakika, uchanganuzi wa rejista ulithibitisha uhusiano mzuri kati ya alama ya kunusa na wakati kutoka kwa usufi chanya kwa SARS-CoV-2. Inajulikana kuwa utendakazi wa kunusa katika COVID-19 unaweza kubadilishwa kwa kiasi kikubwa na kwamba muda mrefu tangu kuanza kwa dalili, wagonjwa wana uwezekano mkubwa wa kuwa na utendaji wa kawaida wa kunusa.<a id=\"xref-ref-17-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-17\">17<\/a>\n<\/p>\n<p id=\"p-24\">Kutokuwepo kwa uhusiano kati ya kizuizi cha pua kilichokadiriwa kibinafsi na tathmini ya harufu ya kibinafsi au ya nusu dhamira inapendekeza kuwa kutofanya kazi kwa kunusa kwa wagonjwa walio na COVID-19 hakukutokana na kizuizi cha pua bali ilikuwa matokeo ya kuvimba kwa epithelium ya kunusa.<a id=\"xref-ref-18-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-18\">18<\/a>\n<\/p>\n<p id=\"p-25\">Masomo machache tu ya awali kwa wagonjwa walio na COVID-19 tathmini ya kibinafsi iliyojumuishwa na upimaji usio na lengo au lengo kwa wagonjwa sawa na ilibaini tofauti kubwa kati ya kuenea kwa kuripotiwa kwa mtu binafsi na kupoteza harufu iliyopimwa.<a id=\"xref-ref-2-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-2\">2\u20134 17<\/a> Kinyume na tafiti hizi, ambapo ulemavu wa kunusa wa kibinafsi ulithibitishwa na ndiyo\/hapana (swali funge), wasomaji wetu walikadiria uwezo wa kunusa kwa kipimo cha nambari 1-10, ambacho kilituwezesha kufanya uchanganuzi wa uunganisho kati ya alama za kibinafsi na lengo. Hatukupata uhusiano wowote kati ya ukadiriaji wa kunusa na upimaji wa nusu lengo katika wagonjwa waliolazwa hospitalini na waliojitenga na COVID-19, huku washiriki wa udhibiti walionyesha uwiano mzuri wa wastani. Ugunduzi huu unapendekeza kuwa kuripoti kibinafsi kwa utendaji wa kunusa kwa wagonjwa walio na COVID-19 sio kutegemewa, hata kwa matumizi ya kipimo sahihi zaidi cha ukadiriaji. Kwa hakika, makubaliano ya chini kati ya utendaji wa kunusa unaoripotiwa na mtu binafsi na kupima lengo sio kipengele tofauti cha upotezaji wa harufu ya COVID-19 na yameelezwa hapo awali kwa vijana na wazee wenye afya njema, na pia kwa wagonjwa walio na matatizo ya utambuzi.<a id=\"xref-ref-19-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-19\">19\u201321<\/a> Kwa kweli, utafiti juu ya watu wenye afya ambao hawajafunzwa ulionyesha kuwa ukadiriaji wa kunusa unahusiana vyema na hali ya hewa ya pua inayotambulika kuliko utendaji unaopimika wa kunusa.<a id=\"xref-ref-21-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-21\">21<\/a>\n<\/p>\n<p id=\"p-26\">Nguvu za utafiti wetu ni matumizi ya mtihani ulioidhinishwa vizuri wa kazi ya kunusa ambayo inaruhusu kuamua viwango tofauti vya dysfunction ya kunusa na kuingizwa kwa wagonjwa waliolazwa hospitalini kikamilifu. Vizuizi ni saizi ndogo ya sampuli na matumizi ya jaribio la vipengee 12. Imeonyeshwa kuwa, katika mazingira ya wagonjwa wa nje, kutegemewa kwa mtihani ni kipengele cha urefu wa mtihani, na vipimo vifupi vya kutambua harufu havielewi sana na upungufu wa kunusa.<a id=\"xref-ref-22-1\" class=\"xref-bibr\" href=\"https:\/\/pmj.bmj.com\/content\/98\/1166\/902?rss=1#ref-22\">22<\/a> Hata hivyo, vipimo vifupi vinaweza kuwa sahihi zaidi katika mazingira ya hospitali, kwa kuwa matokeo ya vipimo vya muda mrefu zaidi yanaweza kuathiriwa na kutokuwa makini na ushirikiano wa kutosha wa wagonjwa wanaougua sana.<\/p>\n<\/div>\n<div class=\"section conclusions\" id=\"sec-13\" readability=\"11.695473251029\">\n<h2 class>Hitimisho<\/h2>\n<p id=\"p-27\">Kinyume na ripoti zinazodokeza kwamba kuwepo kwa upotevu wa kunusa kunaweza kutabiri mwendo mdogo wa ugonjwa, uchunguzi wetu uligundua kwamba idadi kubwa ya wagonjwa wenye ugonjwa mbaya wa kupumua walikuwa na upungufu mkubwa wa kunusa. Wagonjwa wote waliolazwa hospitalini walio na COVID-19 na wagonjwa walio na ugonjwa mbaya ambao walikuwa wamejitenga nyumbani walipata alama mbaya zaidi juu ya upimaji wa kunusa wa kibinafsi na wa nusu ikilinganishwa na vidhibiti vya kiafya, lakini tathmini yao ya utendakazi wa kunusa haikuhusiana na matokeo ya majaribio. Ugunduzi huu unathibitisha kuwa ripoti ya kibinafsi ya kazi ya kunusa kwa wagonjwa walio na COVID-19 haiwezi kutegemewa.<\/p>\n<div class=\"boxed-text\" id=\"boxed-text-1\">\n<h3>Ujumbe kuu<\/h3>\n<ul class=\"list-unord\" id=\"list-1\" readability=\"3.5\">\n<li id=\"list-item-1\" readability=\"5\">\n<p id=\"p-28\">Upungufu wa harufu upo kwa wagonjwa wengi walio na COVID-19, wale walio na ugonjwa huo dhaifu, wanaohitaji kujitenga tu nyumbani, na vile vile katika kundi la wagonjwa sana, wanaohitaji kulazwa hospitalini.<\/p>\n<\/li>\n<li id=\"list-item-2\" readability=\"0\">\n<p id=\"p-29\">Uwiano kati ya tathmini ya kujitathmini na yenye lengo la kunusa kwa wagonjwa walio na COVID-19 ni duni.<\/p>\n<\/li>\n<li id=\"list-item-3\" readability=\"-1\">\n<p id=\"p-30\">Ripoti ya kibinafsi ya utendaji wa kunusa kwa wagonjwa walio na COVID-19 haiwezi kutegemewa.<\/p>\n<\/li>\n<\/ul>\n<\/div>\n<div class=\"boxed-text\" id=\"boxed-text-2\">\n<h3>Maswali ya sasa ya utafiti<\/h3>\n<\/div>\n<div class=\"boxed-text\" id=\"boxed-text-3\">\n<h3>Nini tayari inajulikana juu ya somo<\/h3>\n<\/div>\n<div id=\"DC1\" class=\"supplementary-material\">\n<h3 class>Nyenzo za ziada<\/h3>\n<\/div>\n<\/div>\n<div class=\"section data-availability\" id=\"sec-14\">\n<h2 class>Taarifa ya upatikanaji wa data<\/h2>\n<p id=\"p-41\">Hakuna data inayopatikana.<\/p>\n<\/div>\n<div class=\"section ethics-statement\" id=\"sec-15\" readability=\"6\">\n<h2 class>Kauli za maadili<\/h2>\n<div class=\"section\" id=\"sec-16\">\n<h3>Idhini ya mgonjwa kwa uchapishaji<\/h3>\n<p id=\"p-42\" class=\"ethics-consent-to-publish\">Haitumiki.<\/p>\n<\/div>\n<div class=\"section\" id=\"sec-17\" readability=\"7\">\n<h3>Idhini ya maadili<\/h3>\n<p id=\"p-43\" class=\"ethics-approval\">Utafiti huo uliidhinishwa na Kamati ya Kitaifa ya Maadili ya Kimatibabu ya Jamhuri ya Slovenia.<\/p>\n<\/div>\n<\/div>\n<p><span class=\"highwire-journal-article-marker-end\"><\/span><a href=\"http:\/\/pmj.bmj.com\/cgi\/content\/short\/98\/1166\/902?rss=1\">Chanzo cha matibabu cha kila siku<\/a><\/p>\n<p>","protected":false},"excerpt":{"rendered":"<p><sec><st>Usuli<\/st><\/p>\n<p>Kupoteza harufu ni dalili ya kawaida ya maambukizi ya COVID-19. Tafiti nyingi zilizokagua upungufu wa kunusa katika COVID-19 zilitumia dodoso (tathmini za kimsingi za harufu) na hazikulinganisha matokeo na hatua za kunusa zenye lengo au nusu dhamira. Tulifanya uchunguzi wa harufu katika wagonjwa waliolazwa hospitalini na waliojitenga na COVID-19 na kudhibiti washiriki.<\/p>\n<p><\/sec><br \/>\n<sec><st>Mbinu<\/st><\/p>\n<p>Washiriki 55 wa udhibiti wa COVID-19 na 44 walipimwa harufu, kwa kutumia Vijiti vya Burghart Sniffin &#039;Screening 12 Test&#039;. Washiriki pia walikadiria uwezo wao wa kunusa kwenye mizani ya nambari. Tofauti kati ya vikundi na uwiano kati ya kupoteza harufu na wakati kutoka kwa dalili za papo hapo zilijaribiwa, pamoja na uwiano kati ya matokeo ya mtihani wa harufu na tathmini ya kibinafsi ya harufu.<\/p>\n<p><\/sec><br \/>\n<sec><st>Matokeo<\/st><\/p>\n<p>Wagonjwa waliolazwa hospitalini walio na COVID-19 waliamua kwa usahihi harufu 6.5\/12 ikilinganishwa na 10\/12 katika watu waliojitenga na 11\/12 katika kikundi cha kudhibiti (p&lt;0.001). Hyposmia au anosmia zilikuwepo katika 87.5% ya waliolazwa hospitalini na 29.0% ya wagonjwa waliojitenga (p&lt;0.001). Uwiano kati ya kujitathmini kivyake na matokeo ya kupima harufu haukuwa muhimu katika vikundi vyote viwili vya wagonjwa walio na COVID-19, ilhali kulikuwa na uwiano mzuri wa wastani (p=0.001, mgawo wa uwiano wa Spearman=0.499) katika udhibiti wa washiriki.<\/p>\n<p><\/sec><br \/>\n<sec><st>Hitimisho<\/st><\/p>\n<p>Kinyume na ripoti zingine za hapo awali zilizopendekeza kuwa uwepo wa upotezaji wa kunusa unaweza kutabiri mwendo mdogo wa ugonjwa, utafiti wetu uligundua kuwa idadi kubwa ya wagonjwa waliolazwa hospitalini na COVID-19 walikuwa na ulemavu wa kunusa. Kutokuwepo kwa uwiano kati ya tathmini ya kujitathmini na yenye lengo la kunusa kwa wagonjwa walio na COVID-19 kunaonyesha kuwa tathmini ya harufu ya kibinafsi haiwezi kutegemewa.<\/p>\n<p><\/sec><\/p>","protected":false},"author":2,"featured_media":7597,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":{"page_builder":"","fifu_image_url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/02\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg","fifu_image_alt":"","footnotes":""},"categories":[185],"tags":[],"class_list":["post-7596","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-medical-articles"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: a single-centre experience on 55 cases - Urban Care Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urbancare.clinic\/sw\/tathmini-ya-kunusa-katika-wagonjwa-waliolazwa-hospitalini-na-waliojitenga-na-covid-19-katika-kituo-kimoja-katika-kesi-55\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: a single-centre experience on 55 cases - Urban Care Clinic\" \/>\n<meta property=\"og:description\" content=\"Background Smell loss is a common symptom of COVID-19 infection. Majority of the studies that evaluated olfactory impairment in COVID-19 used questionnaires (subjective smell evaluations) and did not compare the results with objective or semiobjective measures of smell. We performed smell testing in hospitalised and self-isolated patients with COVID-19 and control participants. Methods Fifty-five COVID-19 and 44 control participants underwent smell testing, using Burghart Sniffin&#039; Sticks &lsquo;Screening 12 Test&#039;. Participants also rated their smelling capability on the numerical scale. Differences between groups and correlation between smell loss and time from acute onset of symptoms were tested, as well as correlation between results of smell test and subjective assessment of smell. Results Hospitalised patients with COVID-19 correctly determined 6.5\/12 odorants compared with 10\/12 in the self-isolated and 11\/12 in the control group (p&lt;0.001). Hyposmia or anosmia were present in 87.5% of hospitalised and 29.0% of self-isolated patients (p&lt;0.001). The correlation between subjective self-assessment and results of smell testing was non-significant in both groups of patients with COVID-19, while there was a moderate positive correlation (p=0.001, Spearman&#039;s correlation coefficient=0.499) in control participants. Conclusion Contrary to some previous reports suggesting that the presence of olfactory loss may predict milder course of disease, our study found that a vast majority of hospitalised patients with COVID-19 had prominent olfactory impairment. The absence of correlation between self-rated and objective smell evaluation in patients with COVID-19 indicates that subjective smell assessment is unreliable.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urbancare.clinic\/sw\/tathmini-ya-kunusa-katika-wagonjwa-waliolazwa-hospitalini-na-waliojitenga-na-covid-19-katika-kituo-kimoja-katika-kesi-55\/\" \/>\n<meta property=\"og:site_name\" content=\"Urban Care Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/urbancarezanzibar\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T10:00:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/02\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Urban Care Clinic\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Urban Care Clinic\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"dakika 9\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/\"},\"author\":{\"name\":\"Urban Care Clinic\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\"},\"headline\":\"Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: a single-centre experience on 55 cases\",\"datePublished\":\"2022-11-22T10:00:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/\"},\"wordCount\":1802,\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg\",\"articleSection\":[\"Research Articles\"],\"inLanguage\":\"sw\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/\",\"name\":\"Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: a single-centre experience on 55 cases - Urban Care Clinic\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg\",\"datePublished\":\"2022-11-22T10:00:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/#breadcrumb\"},\"inLanguage\":\"sw\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sw\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/#primaryimage\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg\",\"caption\":\"Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: a single-centre experience on 55 cases\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/urbancare.clinic\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: a single-centre experience on 55 cases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"name\":\"Urban Care Clinic\",\"description\":\"Your Medical Healthcare Clinic in Zanzibar\",\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/urbancare.clinic\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sw\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\",\"name\":\"Urban Care Clinic Zanzibar\",\"alternateName\":\"Urban Care Clinic\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sw\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"width\":500,\"height\":500,\"caption\":\"Urban Care Clinic Zanzibar\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/urbancarezanzibar\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\",\"name\":\"Urban Care Clinic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sw\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"caption\":\"Urban Care Clinic\"},\"url\":\"https:\\\/\\\/urbancare.clinic\\\/sw\\\/author\\\/urban-care-clinic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tathmini ya kunusa katika wagonjwa waliolazwa hospitalini na waliojitenga na COVID-19: uzoefu wa kituo kimoja juu ya kesi 55 - Kliniki ya Utunzaji wa Mjini","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urbancare.clinic\/sw\/tathmini-ya-kunusa-katika-wagonjwa-waliolazwa-hospitalini-na-waliojitenga-na-covid-19-katika-kituo-kimoja-katika-kesi-55\/","og_locale":"en_US","og_type":"article","og_title":"Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: a single-centre experience on 55 cases - Urban Care Clinic","og_description":"Background Smell loss is a common symptom of COVID-19 infection. Majority of the studies that evaluated olfactory impairment in COVID-19 used questionnaires (subjective smell evaluations) and did not compare the results with objective or semiobjective measures of smell. We performed smell testing in hospitalised and self-isolated patients with COVID-19 and control participants. Methods Fifty-five COVID-19 and 44 control participants underwent smell testing, using Burghart Sniffin' Sticks &lsquo;Screening 12 Test'. Participants also rated their smelling capability on the numerical scale. Differences between groups and correlation between smell loss and time from acute onset of symptoms were tested, as well as correlation between results of smell test and subjective assessment of smell. Results Hospitalised patients with COVID-19 correctly determined 6.5\/12 odorants compared with 10\/12 in the self-isolated and 11\/12 in the control group (p&lt;0.001). Hyposmia or anosmia were present in 87.5% of hospitalised and 29.0% of self-isolated patients (p&lt;0.001). The correlation between subjective self-assessment and results of smell testing was non-significant in both groups of patients with COVID-19, while there was a moderate positive correlation (p=0.001, Spearman's correlation coefficient=0.499) in control participants. Conclusion Contrary to some previous reports suggesting that the presence of olfactory loss may predict milder course of disease, our study found that a vast majority of hospitalised patients with COVID-19 had prominent olfactory impairment. The absence of correlation between self-rated and objective smell evaluation in patients with COVID-19 indicates that subjective smell assessment is unreliable.","og_url":"https:\/\/urbancare.clinic\/sw\/tathmini-ya-kunusa-katika-wagonjwa-waliolazwa-hospitalini-na-waliojitenga-na-covid-19-katika-kituo-kimoja-katika-kesi-55\/","og_site_name":"Urban Care Clinic","article_publisher":"https:\/\/www.facebook.com\/urbancarezanzibar","article_published_time":"2022-11-22T10:00:22+00:00","og_image":[{"url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/02\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg","width":1024,"height":1024,"type":"image\/jpeg"}],"author":"Urban Care Clinic","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Urban Care Clinic","Est. reading time":"dakika 9"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/#article","isPartOf":{"@id":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/"},"author":{"name":"Urban Care Clinic","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930"},"headline":"Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: a single-centre experience on 55 cases","datePublished":"2022-11-22T10:00:22+00:00","mainEntityOfPage":{"@id":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/"},"wordCount":1802,"publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"image":{"@id":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/02\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg","articleSection":["Research Articles"],"inLanguage":"sw"},{"@type":"WebPage","@id":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/","url":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/","name":"Tathmini ya kunusa katika wagonjwa waliolazwa hospitalini na waliojitenga na COVID-19: uzoefu wa kituo kimoja juu ya kesi 55 - Kliniki ya Utunzaji wa Mjini","isPartOf":{"@id":"https:\/\/urbancare.clinic\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/#primaryimage"},"image":{"@id":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/02\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg","datePublished":"2022-11-22T10:00:22+00:00","breadcrumb":{"@id":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/#breadcrumb"},"inLanguage":"sw","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/"]}]},{"@type":"ImageObject","inLanguage":"sw","@id":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/#primaryimage","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/02\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/02\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases.jpg","caption":"Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: a single-centre experience on 55 cases"},{"@type":"BreadcrumbList","@id":"https:\/\/urbancare.clinic\/olfactory-evaluation-in-hospitalised-and-self-isolated-patients-with-covid-19-a-single-centre-experience-on-55-cases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/urbancare.clinic\/"},{"@type":"ListItem","position":2,"name":"Olfactory evaluation in hospitalised and self-isolated patients with COVID-19: a single-centre experience on 55 cases"}]},{"@type":"WebSite","@id":"https:\/\/urbancare.clinic\/#website","url":"https:\/\/urbancare.clinic\/","name":"Kliniki ya Huduma ya Mjini","description":"Kliniki yako ya Afya Zanzibar","publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urbancare.clinic\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sw"},{"@type":"Organization","@id":"https:\/\/urbancare.clinic\/#organization","name":"Kliniki ya Huduma ya Mijini Zanzibar","alternateName":"Urban Care Clinic","url":"https:\/\/urbancare.clinic\/","logo":{"@type":"ImageObject","inLanguage":"sw","@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","width":500,"height":500,"caption":"Urban Care Clinic Zanzibar"},"image":{"@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/urbancarezanzibar"]},{"@type":"Person","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930","name":"Kliniki ya Huduma ya Mjini","image":{"@type":"ImageObject","inLanguage":"sw","@id":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","caption":"Urban Care Clinic"},"url":"https:\/\/urbancare.clinic\/sw\/author\/urban-care-clinic\/"}]}},"_links":{"self":[{"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/posts\/7596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/comments?post=7596"}],"version-history":[{"count":0,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/posts\/7596\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/media\/7597"}],"wp:attachment":[{"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/media?parent=7596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/categories?post=7596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urbancare.clinic\/sw\/wp-json\/wp\/v2\/tags?post=7596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}